POWER Magazine

Fives ProSim Launches ProSimPlus Python API, a New Generation of Python Driven Process Simulation

Fives ProSim, a subsidiary of the Fives Group and an expert in industrial process simulation and optimization, announces the release of ProSimPlus Python API. This new solution enables users to run ...
Smithsonian Magazine

Could Python Blood Lead to the Next Generation of Weight-Loss Drugs?

Burmese pythons have pretty irregular eating habits. One of these giant reptiles can swallow an entire antelope whole and then go up to a year and a half without additional meals. Now, scientists have ...
Los Angeles Times

Gen Z is the loneliest generation. Here’s what can help

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred We are more connected than ever before, with ...
Psychology Today

The COVID-19 Generation

Just six short years ago this week, the world shuttered. With the fear of the spread of COVID-19, restaurants closed, businesses went remote, and public spaces went eerily quiet. At universities, ...
Forbes

What Is Generation Jones And Why It’s Reshaping Succession Planning

Forbes contributors publish independent expert analyses and insights. Vibhas Ratanjee studies leadership and culture at Gallup Most talent strategies plan Boomer-to-Gen-X transitions. The actual ...
Wall Street Journal

A New Lost Generation: Why Gen Z Is Unprepared for the Workplace

The workplace can be a tricky place to navigate. Almost everything we do at work—identifying the experts, managing tough feedback from a boss, figuring out how to work in teams made up of different ...
Reuters

Generate Biomedicines shares fall in weak Nasdaq debut for drug developer

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
New York Post

Gen Z — the first generation officially dubbed dumber than the last

Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...
Seeking Alpha

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
FierceBiotech

Flagship-founded antibody biotech Generate is latest to mull IPO

Generate:Biomedicines' anti-TSLP antibody GB-0895 is currently being evaluated in a pair of phase 3 studies for severe asthma. (Stock photo/Getty Images) Clinical-stage antibody company ...